Changeflow GovPing Healthcare & Life Sciences Patent Application for Reducing Food Intake Usi...
Routine Notice Added Draft

Patent Application for Reducing Food Intake Using Plants

Favicon for changeflow.com USPTO Patent Applications - Therapeutics (A61P)
Published
Detected
Email

Summary

The USPTO has published a new patent application (US20260083800A1) detailing methods and compositions using Dichrostachys glomerata or Cissus quadrangularis to reduce food intake or appetite in mammals. The application was filed on September 26, 2024, by inventors Shil Kothari and Julius Enyoug Oben.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a patent application filed with the USPTO, specifically application number US20260083800A1. The application, titled "METHODS AND COMPOSITIONS FOR REDUCING FOOD INTAKE OR APPETITE IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES," describes the use of Dichrostachys glomerata or Cissus quadrangularis to potentially increase GLP-1 levels and reduce food intake, visceral fat, blood lipids, total cholesterol, and total glucose in mammals.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in the pharmaceutical and food industries related to appetite suppression and weight management. Companies involved in developing or marketing related products should monitor the progress of this patent application and any resulting granted patents.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHODS AND COMPOSITIONS FOR REDUCING FOOD INTAKE OR APPETITE IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES

Application US20260083800A1 Kind: A1 Mar 26, 2026

Inventors

Shil Kothari, Julius Enyoug Oben

Abstract

Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing food intake or appetite in a mammal is provided where the composition comprises an effective amount of Dichrostachys glomerata provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

CPC Classifications

A61K 36/48 A61P 3/04 A61K 2236/17 A61K 2236/33

Filing Date

2024-09-26

Application No.

18898550

View original document →

Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
September 26th, 2024
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083800A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Product Labeling
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Food Safety Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!